<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">30937186</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2059-0105</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>NPJ vaccines</Title><ISOAbbreviation>NPJ Vaccines</ISOAbbreviation></Journal><ArticleTitle>Role of innate lymphoid cells and dendritic cells in intradermal immunization of the enterovirus antigen.</ArticleTitle><Pagination><StartPage>14</StartPage><MedlinePgn>14</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">14</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41541-019-0108-6</ELocationID><Abstract><AbstractText>Enterovirus type 71 (EV71) and coxsackievirus A 16 (CA16) are the major pathogens of human hand, foot, and mouth disease (HFMD). In our previous study, intramuscular immunization with the inactivated EV71 vaccine elicited effective immunity, while immunization with the inactivated CA16 vaccine did not. In this report, we focused on innate immune responses elicited by inactivated EV71 and CA16 antigens administered intradermally or intramuscularly. The distributions of the EV71 and CA16 antigens administered intradermally or intramuscularly were not obviously different, but the antigens were detected for a shorter period of time when administered intradermally. The expression levels of NF-&#x3ba;B pathway signaling molecules, which were identified as being capable of activating DCs, ILCs, and T cells, were higher in the intradermal group than in the intramuscular group. Antibodies for the EV71 and CA16 antigens colocalized with ILCs and DCs in skin and muscle tissues under fluorescence microscopy. Interestingly, ILC colocalization decreased over time, while DC colocalization increased over time. ELISpot analysis showed that coordination between DCs and ILCs contributed to successful adaptive immunity against vaccine antigens in the skin. EV71 and/or CA16 antigen immunization via the intradermal route was more capable of significantly increasing neutralizing antibody titers and activating specific T cell responses than immunization via the intramuscular route. Furthermore, neonatal mice born to mothers immunized with the EV71 and CA16 antigens were 100% protected against wild-type EV71 or CA16 viral challenge. Together, our results provide new insights into the development of vaccines for HFMD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Shengtao</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118 Kunming, Yunnan China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118 Kunming, Yunnan China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lian</LastName><ForeName>Yaru</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Aimei Convac BioPharm (Jiangsu) Co., Ltd., 225300 Taizhou, Jiangsu China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Guorun</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118 Kunming, Yunnan China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Aimei Convac BioPharm (Jiangsu) Co., Ltd., 225300 Taizhou, Jiangsu China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Chenhong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Aimei Convac BioPharm (Jiangsu) Co., Ltd., 225300 Taizhou, Jiangsu China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Erxia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Aimei Convac BioPharm (Jiangsu) Co., Ltd., 225300 Taizhou, Jiangsu China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lichun</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118 Kunming, Yunnan China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Xingli</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118 Kunming, Yunnan China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118 Kunming, Yunnan China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118 Kunming, Yunnan China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qihan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118 Kunming, Yunnan China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>NPJ Vaccines</MedlineTA><NlmUniqueID>101699863</NlmUniqueID><ISSNLinking>2059-0105</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>NPJ Vaccines. 2019 Nov 4;4:47. doi: 10.1038/s41541-019-0141-5</RefSource><PMID Version="1">31700692</PMID></CommentsCorrections></CommentsCorrectionsList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>3</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>3</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30937186</ArticleId><ArticleId IdType="pmc">PMC6437170</ArticleId><ArticleId IdType="doi">10.1038/s41541-019-0108-6</ArticleId><ArticleId IdType="pii">108</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Heinsbroek E, Ruitenberg EJ. The global introduction of inactivated polio vaccine can circumvent the oral polio vaccine paradox. Vaccine. 2010;28:3778&#x2013;3783. doi: 10.1016/j.vaccine.2010.02.095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2010.02.095</ArticleId><ArticleId IdType="pubmed">20362626</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandyopadhyay AS, Garon J, Seib K, Orenstein WA. Polio vaccination: past, present and future. Future Microbiol. 2015;10:791&#x2013;808. doi: 10.2217/fmb.15.19.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb.15.19</ArticleId><ArticleId IdType="pubmed">25824845</ArticleId></ArticleIdList></Reference><Reference><Citation>Breiman RF, et al. A multinational, randomized, placebo-controlled trial to assess the immunogenicity, safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young children. Vaccine. 2009;27:5472&#x2013;5479. doi: 10.1016/j.vaccine.2009.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2009.07.002</ArticleId><ArticleId IdType="pubmed">19616493</ArticleId></ArticleIdList></Reference><Reference><Citation>Herremans T, Reimerink JH, Kimman TG, van Der Avoort HG, Koopmans MP. Antibody responses to antigenic sites 1 and 3 of serotype 3 poliovirus after vaccination with oral live attenuated or inactivated poliovirus vaccine and after natural exposure. Clin. Diagn. Lab. Immunol. 2000;7:40&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC95819</ArticleId><ArticleId IdType="pubmed">10618274</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuel BU, Cherian T, Sridharan G, Mukundan P, John TJ. Immune response to intradermally injected inactivated poliovirus vaccine. Lancet. 1991;338:343&#x2013;344. doi: 10.1016/0140-6736(91)90480-D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0140-6736(91)90480-D</ArticleId><ArticleId IdType="pubmed">1677699</ArticleId></ArticleIdList></Reference><Reference><Citation>Soonawala D, et al. Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults. Vaccine. 2013;31:3688&#x2013;3694. doi: 10.1016/j.vaccine.2013.05.104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.05.104</ArticleId><ArticleId IdType="pubmed">23770332</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, et al. Intradermal injection of a fractional dose of an inactivated HFMD vaccine elicits similar protective immunity to intramuscular inoculation of a full dose of an Al(OH)3-adjuvanted vaccine. Vaccine. 2017;35:3709&#x2013;3717. doi: 10.1016/j.vaccine.2017.05.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.05.060</ArticleId><ArticleId IdType="pubmed">28576572</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong C, Goldstein DR. Impact of aging on antigen presentation cell function of dendritic cells. Curr. Opin. Immunol. 2013;25:535&#x2013;541. doi: 10.1016/j.coi.2013.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2013.05.016</ArticleId><ArticleId IdType="pmc">PMC3775944</ArticleId><ArticleId IdType="pubmed">23806201</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson MR, Kaminski JJ, Kurt-Jones EA, Fitzgerald KA. Pattern recognition receptors and the innate immune response to viral infection. Viruses. 2011;3:920&#x2013;940. doi: 10.3390/v3060920.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v3060920</ArticleId><ArticleId IdType="pmc">PMC3186011</ArticleId><ArticleId IdType="pubmed">21994762</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenzie ANJ, Spits H, Eberl G. Innate lymphoid cells in inflammation and immunity. Immunity. 2014;41:366&#x2013;374. doi: 10.1016/j.immuni.2014.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2014.09.006</ArticleId><ArticleId IdType="pubmed">25238094</ArticleId></ArticleIdList></Reference><Reference><Citation>Artis D, Spits H. The biology of innate lymphoid cells. Nature. 2015;517:293&#x2013;301. doi: 10.1038/nature14189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14189</ArticleId><ArticleId IdType="pubmed">25592534</ArticleId></ArticleIdList></Reference><Reference><Citation>Eberl G, Colonna M, Di Santo JP, McKenzie AN. Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology. Science. 2015;348:aaa6566. doi: 10.1126/science.aaa6566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa6566</ArticleId><ArticleId IdType="pmc">PMC5658207</ArticleId><ArticleId IdType="pubmed">25999512</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasteiger G, Rudensky AY. Interactions between innate and adaptive lymphocytes. Nat. Rev. Immunol. 2014;14:631&#x2013;639. doi: 10.1038/nri3726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3726</ArticleId><ArticleId IdType="pmc">PMC4504695</ArticleId><ArticleId IdType="pubmed">25132095</ArticleId></ArticleIdList></Reference><Reference><Citation>Luci C, et al. NKp46+ innate lymphoid cells dampen vaginal CD8 T cell responses following local immunization with a cholera toxin-based vaccine. PLoS ONE. 2015;10:e0143224. doi: 10.1371/journal.pone.0143224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0143224</ArticleId><ArticleId IdType="pmc">PMC4668070</ArticleId><ArticleId IdType="pubmed">26630176</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, et al. Pathologic and immunologic characteristics of coxsackievirus A16 infection in Rhesus Macaques. Virology. 2017;500:198&#x2013;208. doi: 10.1016/j.virol.2016.10.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2016.10.031</ArticleId><ArticleId IdType="pubmed">27829175</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao T, et al. Dynamic interaction of enterovirus 71 and dendritic cells in infected neonatal Rhesus Macaques. Front. Cell. Infect. Microbiol. 2017;7:171. doi: 10.3389/fcimb.2017.00171.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2017.00171</ArticleId><ArticleId IdType="pmc">PMC5423916</ArticleId><ArticleId IdType="pubmed">28540257</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, et al. Similar protective immunity induced by an inactivated enterovirus 71 (EV71) vaccine in neonatal rhesus macaques and children. Vaccine. 2015;33:6290&#x2013;6297. doi: 10.1016/j.vaccine.2015.09.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.09.047</ArticleId><ArticleId IdType="pubmed">26419198</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, et al. Coxsackievirus A 16 infection does not interfere with the specific immune response induced by an enterovirus 71 inactivated vaccine in rhesus monkeys. Vaccine. 2014;32:4436&#x2013;4442. doi: 10.1016/j.vaccine.2014.06.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2014.06.062</ArticleId><ArticleId IdType="pubmed">24958699</ArticleId></ArticleIdList></Reference><Reference><Citation>Update: vaccine side effects, adverse reactions, contraindications, and precautions. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep.45, 1&#x2013;35 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8801442</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook IF. Best vaccination practice and medically attended injection site events following deltoid intramuscular injection. Human. Vaccin. Immunother. 2015;11:1184&#x2013;1191. doi: 10.1080/21645515.2015.1017694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2015.1017694</ArticleId><ArticleId IdType="pmc">PMC4514326</ArticleId><ArticleId IdType="pubmed">25868476</ArticleId></ArticleIdList></Reference><Reference><Citation>Steigler P, et al. BCG vaccination drives accumulation and effector function of innate lymphoid cells in murine lungs. Immunol. Cell Biol. 2018;96:379&#x2013;389. doi: 10.1111/imcb.12007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imcb.12007</ArticleId><ArticleId IdType="pubmed">29363172</ArticleId></ArticleIdList></Reference><Reference><Citation>Withers DR. Innate lymphoid cell regulation of adaptive immunity. Immunology. 2016;149:123&#x2013;130. doi: 10.1111/imm.12639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12639</ArticleId><ArticleId IdType="pmc">PMC5011676</ArticleId><ArticleId IdType="pubmed">27341319</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun SC. The non-canonical NF-kappaB pathway in immunity and inflammation. Nat. Rev. Immunol. 2017;17:545&#x2013;558. doi: 10.1038/nri.2017.52.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2017.52</ArticleId><ArticleId IdType="pmc">PMC5753586</ArticleId><ArticleId IdType="pubmed">28580957</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortha A, Burrows K. Cytokine networks between innate lymphoid cells and myeloid cells. Front. Immunol. 2018;9:191. doi: 10.3389/fimmu.2018.00191.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00191</ArticleId><ArticleId IdType="pmc">PMC5808287</ArticleId><ArticleId IdType="pubmed">29467768</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura A, Osonoi T, Terauchi Y. Relationship between urinary sodium excretion and pioglitazone-induced edema. J. Diabetes Investig. 2010;1:208&#x2013;211. doi: 10.1111/j.2040-1124.2010.00046.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2040-1124.2010.00046.x</ArticleId><ArticleId IdType="pmc">PMC4020723</ArticleId><ArticleId IdType="pubmed">24843434</ArticleId></ArticleIdList></Reference><Reference><Citation>Huntington ND, Carpentier S, Vivier E, Belz GT. Innate lymphoid cells: parallel checkpoints and coordinate interactions with T cells. Curr. Opin. Immunol. 2016;38:86&#x2013;93. doi: 10.1016/j.coi.2015.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2015.11.008</ArticleId><ArticleId IdType="pubmed">26736074</ArticleId></ArticleIdList></Reference><Reference><Citation>Austyn, J. M. Dendritic cells in the immune system-history, lineages, tissues, tolerance, and immunity. Microbiol Spectr. 4, 1&#x2013;50 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">28087939</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickman HD, et al. Chemokines control naive CD8+ T cell selection of optimal lymph node antigen presenting cells. J. Exp. Med. 2011;208:2511&#x2013;2524. doi: 10.1084/jem.20102545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20102545</ArticleId><ArticleId IdType="pmc">PMC3256957</ArticleId><ArticleId IdType="pubmed">22042976</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Lastra S, et al. A functional DC cross talk promotes human ILC homeostasis in humanized mice. Blood Adv. 2017;1:601&#x2013;614. doi: 10.1182/bloodadvances.2017004358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2017004358</ArticleId><ArticleId IdType="pmc">PMC5728352</ArticleId><ArticleId IdType="pubmed">29296702</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong E, et al. Migratory dendritic cells, group 1 innate lymphoid cells, and inflammatory monocytes collaborate to recruit NK cells to the virus-infected lymph node. Cell Rep. 2018;24:142&#x2013;154. doi: 10.1016/j.celrep.2018.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.06.004</ArticleId><ArticleId IdType="pmc">PMC6232077</ArticleId><ArticleId IdType="pubmed">29972776</ArticleId></ArticleIdList></Reference><Reference><Citation>Mellman I. Dendritic cells: master regulators of the immune response. Cancer Immunol. Res. 2013;1:145&#x2013;149. doi: 10.1158/2326-6066.CIR-13-0102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2326-6066.CIR-13-0102</ArticleId><ArticleId IdType="pubmed">24777676</ArticleId></ArticleIdList></Reference><Reference><Citation>von Burg N, Turchinovich G, Finke D. Maintenance of Immune Homeostasis through ILC/T Cell Interactions. Front. Immunol. 2015;6:416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4534831</ArticleId><ArticleId IdType="pubmed">26322047</ArticleId></ArticleIdList></Reference><Reference><Citation>Bando JK, Colonna M. Innate lymphoid cell function in the context of adaptive immunity. Nat. Immunol. 2016;17:783&#x2013;789. doi: 10.1038/ni.3484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3484</ArticleId><ArticleId IdType="pmc">PMC5156404</ArticleId><ArticleId IdType="pubmed">27328008</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, et al. An inactivated enterovirus 71 vaccine in healthy children. New Engl. J. Med. 2014;370:829&#x2013;837. doi: 10.1056/NEJMoa1303224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1303224</ArticleId><ArticleId IdType="pubmed">24571755</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson KM, Duintjer Tebbens RJ. Modeling the dynamics of oral poliovirus vaccine cessation. J. Infect. Dis. 2014;210(Suppl 1):S475&#x2013;S484. doi: 10.1093/infdis/jit845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jit845</ArticleId><ArticleId IdType="pubmed">25316870</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu H. Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan. Vaccine. 2016;34:1975&#x2013;1985. doi: 10.1016/j.vaccine.2014.11.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2014.11.015</ArticleId><ArticleId IdType="pubmed">25448090</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, et al. Pathogenesis study of enterovirus 71 infection in rhesus monkeys. Lab. Investig. 2011;91:1337&#x2013;1350. doi: 10.1038/labinvest.2011.82.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.2011.82</ArticleId><ArticleId IdType="pubmed">21555996</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q, et al. Coxsackievirus cloverleaf RNA containing a 5&#x2019; triphosphate triggers an antiviral response via RIG-I activation. PLoS ONE. 2014;9:e95927. doi: 10.1371/journal.pone.0095927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0095927</ArticleId><ArticleId IdType="pmc">PMC3997492</ArticleId><ArticleId IdType="pubmed">24759703</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiao HB, et al. Toll-like receptor 9-mediated protection of enterovirus 71 infection in mice is due to the release of danger-associated molecular patterns. J. Virol. 2014;88:11658&#x2013;11670. doi: 10.1128/JVI.00867-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00867-14</ArticleId><ArticleId IdType="pmc">PMC4178751</ArticleId><ArticleId IdType="pubmed">25078697</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim BS. Innate lymphoid cells in the skin. J. Invest. Dermatol. 2015;135:673&#x2013;678. doi: 10.1038/jid.2014.401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jid.2014.401</ArticleId><ArticleId IdType="pmc">PMC4556524</ArticleId><ArticleId IdType="pubmed">25339380</ArticleId></ArticleIdList></Reference><Reference><Citation>Resik S, et al. Needle-free jet injector intradermal delivery of fractional dose inactivated poliovirus vaccine: association between injection quality and immunogenicity. Vaccine. 2015;33:5873&#x2013;5877. doi: 10.1016/j.vaccine.2015.06.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.06.071</ArticleId><ArticleId IdType="pubmed">26192350</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Jackson RJ, Ranasinghe C. Vaccination route can significantly alter the innate lymphoid cell subsets: a feedback between IL-13 and IFN-gamma. NPJ Vaccin. 2018;3:10. doi: 10.1038/s41541-018-0048-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-018-0048-6</ArticleId><ArticleId IdType="pmc">PMC5847557</ArticleId><ArticleId IdType="pubmed">29560282</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarazona S, et al. Data quality aware analysis of differential expression in RNA-seq with NOISeq R/Bioc package. Nucleic Acids Res. 2015;43:e140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4666377</ArticleId><ArticleId IdType="pubmed">26184878</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzi M. Sampling variation of the fifty percent end-point, determined by the Reed-Muench (Behrens) method. Human. Biol. 1950;22:151&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">14778593</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, et al. Study of the integrated immune response induced by an inactivated EV71 vaccine. PLoS ONE. 2013;8:e54451. doi: 10.1371/journal.pone.0054451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0054451</ArticleId><ArticleId IdType="pmc">PMC3553120</ArticleId><ArticleId IdType="pubmed">23372725</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Z, et al. Immunogenicity and cross-reactivity of four Coxsackie virus group A type 16 strains. Chin. J. Biol. 2013;10:1366&#x2013;1375.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>